CenExel Clinical Research

CenExel Clinical Research

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $150M

Overview

CenExel Clinical Research, founded in 2017, is a private clinical research services company operating a network of dedicated research sites. It functions as a site-level partner for sponsors and CROs, offering patient recruitment, trial execution, and data collection services. The company emphasizes operational excellence, significant collective investigator experience, and large, well-equipped facilities to accelerate clinical development for its clients. Its business model is purely service-based, generating revenue from contracted research services.

Women’s HealthGastroenterology & HepatologyInfectious Disease & VaccinesAsian BridgingHealthy Volunteer

Technology Platform

Operational platform consisting of a network of dedicated clinical research sites ('Centers of Excellence') with standardized procedures, large-scale facilities (inpatient beds, on-site labs), and integrated patient recruitment and trial management systems.

Funding History

2
Total raised:$150M
Series B$100M
Series A$50M

Opportunities

Growth in global clinical trial spending and the persistent need for reliable, high-enrolling sites creates strong demand.
The trend towards complex, inpatient-requiring studies (e.g., Phase 1, biosimilars) plays to the strength of its large, dedicated facilities.
Expansion of its site network into new geographic or therapeutic areas could drive further growth.

Risk Factors

Operational risk from quality or compliance failures at any site could damage the entire network's reputation.
High competition in the site services market creates pricing pressure.
Revenue is project-based and vulnerable to sponsor decisions to delay or cancel trials.

Competitive Landscape

CenExel competes in the fragmented clinical research site sector against academic medical centers, hospital-based research institutes, and other private site networks (e.g., ICON plc's site network, Parexel's affiliated sites, and regional players). Its key differentiators are its large, sponsor-dedicated facilities and emphasis on high-volume, professionally-managed trial execution, as opposed to smaller, physician-investigator practices.